Age-dependent effects of TWEAK/Fn14 receptor activation on neural progenitor cells

Journal of Neuroscience Research

Volumn 85, Issue 16, 2007, Pages 3535-3544

  Hamill, C A ^a   Michaelson, J S ^b   Hahm, Kyungmin ^b   Burkly, Linda C ^b   Kessler, J A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b BIOGEN   (United States)

Author keywords

Axon elongation; Cytokine; Neural progenitor cells; Proliferation

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR LIKE WEAK INDUCER OF APOPTOSIS PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; DEVELOPMENTAL STAGE; EMBRYO; EMBRYO DEVELOPMENT; MOUSE; NERVE FIBER; NERVE FIBER GROWTH; NEURAL STEM CELL; NONHUMAN; POSTNATAL DEVELOPMENT; PRENATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION;

AGING; ANIMALS; ANIMALS, NEWBORN; ANTIBODIES; BRAIN; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GROWTH CONES; MICE; NEURONS; RECEPTORS, TUMOR NECROSIS FACTOR; STEM CELLS; TUMOR NECROSIS FACTORS;

EID: 36049002535     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21443     Document Type: Article

References (45)

1. Banker GA and Waxman, AB. 1988. In: Lasek RJ, Black, editors. Intrinsic Determinants of Neuronal Form and Function. New York: Liss. p 1-58.
2. Baxter FO, Came PJ, Abell K, Kedjouar B, Huth M, Rajewsky K, Pasparakis M, Watson CJ. 2006. IKKbeta/2 induces TWEAK and apoptosis in mammary epithelial cells. Development 133:3485-3494.
3. Brown SA, Richards CM, Hanscom HN, Feng SL, Winkles JA. 2003. The Fn14 cytoplasmic tail binds tumour-necrosis-factor-receptor-associated factors 1, 2, 3 and 5 and mediates nuclear factor-kappaB activation. Biochem J 371(Pt 2):395-403.
4. Campbell S, Burkly LC, Gao HX, Berman JW, Su L, Browning B, Zheng T, Schiffer L, Michaelson JS, Putterman C. 2006. Proinflammatory effects of TWEAK/Fn14 interactions in glomerular mesangial cells. J Immunol 176:1889-1898.
5. Chicheportiche Y, Bourdon PR, Xu H, Hsu YM, Scott H, Hession C, Garcia I, Browning JL. 1997. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J Biol Chem 272:32401-32410.
6. Cohen GM. 1997. Caspases: the executioners of apoptosis. Biochem J 326(Pt 1):1-16.
7. Desplat-Jego S, Varriale S, Creidy R, Terra R, Bernard D, Khrestchatisky M, Izui S, Chicheportiche Y, Boucraut J. 2002. TWEAK is expressed by glial cells, induces astrocyte proliferation and increases EAE severity. J Neuroimmunol 133(1-2):116-123.
8. Dickson BJ. 2001. Rho GTPases in growth cone guidance. Curr Opin Neurobiol 11(1):103-110.
9. Dogra C, Changotra H, Mohan S, Kumar A. 2006. Tumor necrosis factor-like weak inducer of apoptosis inhibits skeletal myogenesis through sustained activation of nuclear factor-kappaB and degradation of MyoD protein. J Biol Chem 281:10327-10336.
10. Donohue PJ, Richards CM, Brown SA, Hanscom HN, Buschman J, Thangada S, Hla T, Williams MS, Winkles JA. 2003. TWEAK is an endothelial cell growth and chemotactic factor that also potentiates FGF-2 and VEGF-A mitogenic activity. Arterioscler Thromb Vasc Biol 23:594-600.
11. Felli N, Pedini F, Zeuner A, Petrucci E, Testa U, Conticello C, Biffoni M, Di Cataldo A, Winkles JA, Peschle C, De Maria R. 2005. Multiple members of the TNF superfamily contribute to IFN-gamma-mediated inhibition of erythropoiesis. J Immunol 175:1464-1472.
12. Girgenrath M, Weng S, Kostek CA, Browning B, Wang M, Brown SA, Winkles JA, Michaelson JS, Allaire N, Schneider P, Scott ML, Hsu YM, Yagita H, Flavell RA, Miller JB, Burkly LC, Zheng TS. 2006. TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regeneration. EMBO J 25:5826-5839.
13. Han S, Yoon K, Lee K, Kim K, Jang H, Lee NK, Hwang K, Young Lee S. 2003. TNF-related weak inducer of apoptosis receptor, a TNF receptor superfamily member, activates NF-kappa B through TNF receptor-associated factors. Biochem Biophys Res Commun 305:789-796.
14. Jakubowski A, Ambrose C, Parr M, Lincecum JM, Wang MZ, Zheng TS, Browning B, Michaelson JS, Baetscher M, Wang B, Bissell DM, Burkly LC. 2005. TWEAK induces liver progenitor cell proliferation. J Clin Invest 115:2330-2340.
15. Jakubowski A, Browning B, Lukashev M, Sizing I, Thompson JS, Benjamin CD, Hsu YM, Ambrose C, Zheng TS, Burkly LC. 2002. Dual role for TWEAK in angiogenic regulation. J Cell Sci 115(Pt 2):267-274.
16. Kelly CM, Tyers P, Borg MT, Svendsen CN, Dunnett SB, Rosser AE. 2005. EGF and FGF-2 responsiveness of rat and mouse neural precursors derived from the embryonic CNS. Brain Res Bull 68(1-2):83-94.
17. Kitchens DL, Snyder EY, Gottlieb DI. 1994. FGF and EGF are mitogens for immortalized neural progenitors. J Neurobiol 25:797-807.
18. Kuhn HG, Winkler J, Kempermann G, Thai LJ, Gage FH. 1997. Epidermal growth factor and fibroblast growth factor-2 have different effects on neural progenitors in the adult rat brain. J Neurosci 17:5820-5829.
19. Lynch CN, Wang YC, Lund JK, Chen YW, Leal JA, Wiley SR. 1999. TWEAK induces angiogenesis and proliferation of endothelial cells. J Biol Chem 274:8455-8459.
20. Mabie PC, Mehler MF, Kessler JA. 1999. Multiple roles of bone morphogenetic protein signaling in the regulation of cortical cell number and phenotype. J Neurosci 19:7077-7088.
21. Maecker H, Varfolomeev E, Kischkel F, Lawrence D, LeBlanc H, Lee W, Hurst S, Danilenko D, Li J, Filvaroff E, Yang B, Daniel D, Ashkenazi A. 2005. TWEAK attenuates the transition from innate to adaptive immunity. Cell 123:931-944.
22. Mehler MF, Mabie PC, Zhu G, Gokhan S, Kessler JA. 2000. Developmental changes in progenitor cell responsiveness to bone morphogenetic proteins differentially modulate progressive CNS lineage fate. Dev Neurosci 22(1-2):74-85.
23. Meighan-Mantha RL, Hsu DK, Guo Y, Brown SA, Feng SL, Peifley KA, Alberts GF, Copeland NG, Gilbert DJ, Jenkins NA, Richards CM, Winkles JA. 1999. The mitogen-inducible Fn14 gene encodes a type I transmembrane protein that modulates fibroblast adhesion and migration. J Biol Chem 274:33166-33176.
24. Meyer G, Feldman EL. 2002. Signaling mechanisms that regulate actin-based motility processes in the nervous system. J Neurochem 83:490-503.
25. Michaelson JS, Cho S, Browning B, Zheng TS, Lincecum JM, Wang MZ, Hsu YM, Burkly LC. 2005. Tweak induces mammary epithelial branching morphogenesis. Oncogene 24:2613-2624.
26. Nakashima K, Wiese S, Yanagisawa M, Arakawa H, Kimura N, Hisatsune T, Yoshida K, Kishimoto T, Sendtner M, Taga T. 1999. Developmental requirement of gp130 signaling in neuronal survival and astrocyte differentiation. J Neurosci 19:5429-5434.
27. Nakayama M, Ishidoh K, Kayagaki N, Kojima Y, Yamaguchi N, Nakano H, Kominami E, Okumura K, Yagita H. 2002. Multiple pathways of TWEAK-induced cell death. J Immunol 168:734-743.
28. Nakayama M, Ishidoh K, Kojima Y, Harada N, Kominami E, Okumura K, Yagita H. 2003. Fibroblast growth factor-inducible 14 mediates multiple pathways of TWEAK-induced cell death. J Immunol 170:341-348.
29. Nakayama M, Kayagaki N, Yamaguchi N, Okumura K, Yagita H. 2000. Involvement of TWEAK in interferon gamma-stimulated monocyte cytotoxicity. J Exp Med 192:1373-1380.
30. Ng J, Nardine T, Harms M, Tzu J, Goldstein A, Sun Y, Dietzl G, Dickson BJ, Luo L. 2002. Rac GTPases control axon growth, guidance and branching. Nature 416:442-447.
31. Perper SJ, Browning B, Burkly LC, Weng S, Gao C, Giza K, Su L, Tarilonte L, Crowell T, Rajman L, Runkel L, Scott M, Atkins GJ, Findlay DM, Zheng TS, Hess H. 2006. TWEAK is a novel arthritogenic mediator. J Immunol 177:2610-2620.
32. Potrovita I, Zhang W, Burkly L, Hahm K, Lincecum J, Wang MZ, Maurer MH, Rossner M, Schneider A, Schwaninger M. 2004. Tumor necrosis factor-like weak inducer of apoptosis-induced neurodegeneration. J Neurosci 24:8237-8244.
33. Reynolds BA, Rietze RL. 2005. Neural stem cells and neurospheres - re-evaluating the relationship. Nat Methods 2:333-336.
34. Saas P, Boucraut J, Walker PR, Quiquerez AL, Billot M, Desplat-Jego S, Chicheportiche Y, Dietrich PY. 2000. TWEAK stimulation of astrocytes and the proinflammatory consequences. Glia 32(1):102-107.
35. Saitoh T, Nakayama M, Nakano H, Yagita H, Yamamoto N, Yamaoka S. 2003. TWEAK induces NF-kappaB2 p100 processing and long lasting NF-kappaB activation. J Biol Chem 278:36005-36012.
36. Schneider P, Schwenzer R, Haas E, Muhlenbeck F, Schubert G, Scheurich P, Tschopp J, Wajant H. 1999. TWEAK can induce cell death via endogenous TNF and TNF receptor 1. Eur J Immunol 29:1785-1792.
37. Sun Y, Nadal-Vicens M, Misono S, Lin MZ, Zubiaga A, Hua X, Fan G, Greenberg ME. 2001. Neurogenin promotes neurogenesis and inhibits glial differentiation by independent mechanisms. Cell 104:365-376.
38. Takizawa T, Nakashima K, Namihira M, Ochiai W, Uemura A, Yanagisawa M, Fujita N, Nakao M, Taga T. 2001. DNA methylation is a critical cell-intrinsic determinant of astrocyte differentiation in the fetal brain. Dev Cell 1:749-758.
39. Tanabe K, Bonilla I, Winkles JA, Strittmatter SM. 2003. Fibroblast growth factor-inducible-14 is induced in axotomized neurons and promotes neurite outgrowth. J Neurosci 23:9675-9686.
40. Vince JE, Silke J. 2006. TWEAK shall inherit the earth. Cell Death Differ 13:1842-1844.
41. Wiley SR, Cassiano L, Lofton T, Davis-Smith T, Winkles JA, Lindner V, Liu H, Daniel TO, Smith CA, Fanslow WC. 2001. A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis. Immunity 15:837-846.
42. Xu H, Okamoto A, Ichikawa J, Ando T, Tasaka K, Masuyama K, Ogawa H, Yagita H, Okumura K, Nakao A. 2004. TWEAK/Fn14 interaction stimulates human bronchial epithelial cells to produce IL-8 and GM-CSF. Biochem Biophys Res Commun 318:422-427.
43. Yepes M, Brown SA, Moore EG, Smith EP, Lawrence DA, Winkles JA. 2005. A soluble Fn14-Fc decoy receptor reduces infarct volume in a murine model of cerebral ischemia. Am J Pathol 166:511-520.
44. Zhu G, Mehler MF, Mabie PC, Kessler JA. 1999. Developmental changes in progenitor cell responsiveness to cytokines. J Neurosci Res 56(2):131-145.
45. Zhang X, Winkles JA, Gongora MC, Polavarapu R, Michaelson JS, Hahm K, Burkly L, Friedman M, Li XJ, Yepes M. 2007. TWEAK-Fn14 pathway inhibition protects the integrity of the neurovascular unit during cerebral ischemia J Cereb Blood Flow Metab 27:534-544.